Position added successfully to: BOTHELL, Wash. - Immunome, Inc. (NASDAQ:IMNM), a biotechnology firm specializing in the development of cancer
Ketki Saxena is the Chief Editor for Canada at Investing.com. With a focus on financial news and market trends, Ketki covers a wide range of topics including currency exchange rates, stock market movements, and industry developments. Her articles provide valuable insights and analysis for investors and individuals interested in the Canadian market.